Latest NEA Management Company, LLC Stock Portfolio
NEA Management Company, LLC Performance:
2024 Q3: 11.97%YTD: -3.2%2023: 26.99%
Performance for 2024 Q3 is 11.97%, and YTD is -3.2%, and 2023 is 26.99%.
About NEA Management Company, LLC and 13F Hedge Fund Stock Holdings
NEA Management Company, LLC is a hedge fund based in CHEVY CHASE, MD. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $25.9 Billions. In it's latest 13F Holdings report, NEA Management Company, LLC reported an equity portfolio of $1.8 Billions as of 30 Sep, 2024.
The top stock holdings of NEA Management Company, LLC are ACLX, , VRNA. The fund has invested 17% of it's portfolio in ARCELLX INC and 16.6% of portfolio in TEMPUS AI INC.
The fund managers got completely rid off REGULUS THERAPEUTICS INC (RGLS), TUYA INC (TUYA) and SENTI BIOSCIENCES INC (SNTI) stocks. They significantly reduced their stock positions in MYND AI INC. NEA Management Company, LLC opened new stock positions in MBX BIOSCIENCES INC, REGULUS THERAPEUTICS INC (RGLS) and SENTI BIOSCIENCES INC (SNTI). The fund showed a lot of confidence in some stocks as they added substantially to TEMPUS AI INC and IKENA ONCOLOGY INC (IKNA).
The top stock holdings of NEA Management Company, LLC are ACLX, , VRNA. The fund has invested 17% of it's portfolio in ARCELLX INC and 16.6% of portfolio in TEMPUS AI INC.
The fund managers got completely rid off REGULUS THERAPEUTICS INC (RGLS), TUYA INC (TUYA) and SENTI BIOSCIENCES INC (SNTI) stocks. They significantly reduced their stock positions in MYND AI INC. NEA Management Company, LLC opened new stock positions in MBX BIOSCIENCES INC, REGULUS THERAPEUTICS INC (RGLS) and SENTI BIOSCIENCES INC (SNTI). The fund showed a lot of confidence in some stocks as they added substantially to TEMPUS AI INC and IKENA ONCOLOGY INC (IKNA).
NEA Management Company, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that NEA Management Company, LLC made a return of 11.97% in the last quarter. In trailing 12 months, it's portfolio return was 14.89%.
New Buys
| Ticker | $ Bought |
|---|---|
| mbx biosciences inc | 93,904,300 |
| zenas biopharma inc | 44,228,000 |
| regulus therapeutics inc | 10,154,400 |
| senti biosciences inc | 1,000,310 |
New stocks bought by NEA Management Company, LLC
Additions
| Ticker | % Inc. |
|---|---|
| tempus ai inc | 17.78 |
| ikena oncology inc | 5.26 |
Additions to existing portfolio by NEA Management Company, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| mynd ai inc | -94.34 |
| affimed nv | 0.00 |
NEA Management Company, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| regulus therapeutics inc | -11,577,400 |
| tuya inc | -5,576,270 |
| senti biosciences inc | -1,221,620 |
NEA Management Company, LLC got rid off the above stocks
Sector Distribution
NEA Management Company, LLC has about 63.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 63.5 |
| Others | 26.7 |
| Consumer Defensive | 5.6 |
| Technology | 3.7 |
Market Cap. Distribution
NEA Management Company, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 38.8 |
| UNALLOCATED | 26.7 |
| SMALL-CAP | 23.7 |
| MICRO-CAP | 9.9 |
Stocks belong to which Index?
About 54.8% of the stocks held by NEA Management Company, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.8 |
| Others | 45.2 |
NEA Management Company, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of NEA Management Company, LLC
NEA Management Company, LLC has 42 stocks in it's portfolio. About 76.9% of the portfolio is in top 10 stocks. CRSP proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for NEA Management Company, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 17.04 | 3,745,260 | 312,767,000 | unchanged | 0.00 | ||
| ADAP | adaptimmune therapeutics plc | 0.88 | 17,079,800 | 16,225,800 | unchanged | 0.00 | ||
| ALLK | allakos inc | 0.22 | 6,147,260 | 3,995,720 | unchanged | 0.00 | ||
| AUPH | aurinia pharmaceuticals inc | 1.58 | 3,969,830 | 29,098,900 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics inc | 1.05 | 4,448,760 | 19,352,100 | unchanged | 0.00 | ||
| BHG | neuehealth inc | 0.78 | 2,726,920 | 14,234,500 | unchanged | 0.00 | ||
| BZFD | buzzfeed inc | 0.56 | 3,833,470 | 10,235,400 | unchanged | 0.00 | ||
| CELC | celcuity inc | 1.01 | 1,250,000 | 18,637,500 | unchanged | 0.00 | ||
| COUR | coursera inc | 5.57 | 12,867,800 | 102,170,000 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 4.06 | 1,587,850 | 74,597,400 | unchanged | 0.00 | ||
| CSBR | champions oncology inc | 0.46 | 1,713,720 | 8,345,820 | unchanged | 0.00 | ||
| CVRX | cvrx inc | 1.14 | 2,370,540 | 20,884,500 | unchanged | 0.00 | ||
| DM | desktop metal inc | 0.37 | 1,439,890 | 6,724,300 | unchanged | 0.00 | ||
| GERN | geron corp | 0.69 | 2,776,410 | 12,604,900 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc | 2.22 | 7,692,300 | 40,769,200 | unchanged | 0.00 | ||
| GOSS | gossamer bio inc | 0.98 | 18,093,000 | 17,912,100 | unchanged | 0.00 | ||
| IKNA | ikena oncology inc | 0.06 | 600,063 | 1,038,110 | added | 5.26 | ||
| INZY | inozyme pharma inc | 0.70 | 2,437,690 | 12,749,100 | unchanged | 0.00 | ||
| IVA | inventiva sa | 0.15 | 1,462,590 | 2,749,660 | unchanged | 0.00 | ||
| LXRX | lexicon pharmaceuticals inc | 0.20 | 2,382,290 | 3,740,190 | unchanged | 0.00 | ||